Ordination af Thalidomide Celgene bør begrænses til 4 ugers behandling for kvinder i den fertile alder, og en ny ordination er påkrævet ved fortsat behandling.
For women of childbearing potential, prescriptions of Thalidomide Celgene should be limited to 4 weeks of treatment and continuation of treatment requires a new prescription.